← Evidence map

ReviewImmunotherapy advances2025

Cancer vaccine trial evaluations: immunobridging and potential immunological endpoints.

Ahmed Hussain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40438385